Document AbbVie Inc. Guidance Including the Impact of Acquired IPR D and Milestones Expense (Unaudited) (in millions, except per share data) Quarter Ended
Sunday, March 31, 2024 1 min read
Key Takeaway: AbbVie Inc. has provided guidance for its financial performance for the quarter ended March 31, 2024, and for the full year ended December 31, 2024. This guidance includes the impact of an acquired IPR D and related milestones expense amounting to $164 million. Adjusted diluted EPS for Q1 is projected to range from $2.18 to $2.22, while for the full year, it is estimated between $10.97 and $11.17. The company has specified that the guidance excludes any potential expenses from acquired IPR D and milestones incurred after the first quarter of 2024 due to unpredictability.
Market Sentiment Analysis
CONCERNS & RISKS
The guidance includes a notable expense related to acquired IPR D and milestones, potentially impacting earnings.
There is uncertainty regarding future expenses beyond Q1 2024, which cannot be reliably forecasted.
Full Press Release Details
Guidance Including the Impact of Acquired IPR D and Milestones Expense
(in millions, except per share data)
Quarter Ended March 31, 2024
Full-Year Ended December 31, 2024
Acquired IPR D and Milestones Expense
Adjusted Diluted EPS Range
Acquired IPR D and Milestones Expense
Adjusted Diluted EPS Range
Low
High
Low
High
Previously announced guidance excluding Q1 2024 acquired IPR D and milestones expense
$
-
$
2.26
$
2.30
$
-
$
11.05
$
11.25
Q1 2024 acquired IPR D and milestones expense
164
(0.08)
(0.08)
164
(0.08)
(0.08)
Guidance including Q1 2024 acquired IPR D and milestones expense a
$
164
$
2.18
$
2.22
$
164
$
10.97
$
11.17
a The Company's 2024 adjusted diluted EPS guidance excludes any impact from acquired IPR D and milestones expense that may be incurred beyond the first quarter of 2024, as both cannot be reliably forecasted.
Frequently Asked Questions
What is the acquired IPR D and milestones expense for Q1 2024?
The acquired IPR D and milestones expense for Q1 2024 is $164 million.
How does Q1 2024 impact the adjusted diluted EPS guidance?
Including Q1 2024 expense, the adjusted diluted EPS guidance is $2.18 to $2.22.
What is the adjusted diluted EPS guidance for the full year 2024?
For the full year 2024, the adjusted diluted EPS guidance is $10.97 to $11.17.
Is future acquired IPR D and milestones expense predictable?
The guidance excludes future expenses beyond Q1 2024 due to unpredictability.